Clinical Trial Update: Lantus Versus Levemir Treat-To-Target [Phase 4]

View source ↗

Summary

Phase 4 trial comparing Lantus (insulin glargine) and Levemir (insulin detemir) using a treat-to-target approach in Type 2 diabetes. The study status is complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Lantus (insulin glargine)
• Levemir (insulin detemir)

Snippet

Sponsor: Sanofi | Conditions: Diabetes Mellitus, Type 2 | Phase 4 | Status: COMPLETED